EUVIMEDEUVIMED entdecken
LeserbriefKommentar

Isolated limb perfusion versus radiotherapy in the neoadjuvant setting of extremity soft tissue sarcoma

Cheng-Ju Wu, Yung-Shuo Kao

European Journal of Surgical Oncology · 2023

DOI: 10.1016/j.ejso.2023.04.014 ↗

Kurz gefasst

Leserbrief in der Zeitschrift European Journal of Surgical Oncology, 2023. Verfasst von Cheng-Ju Wu und 1 weiteren Autor:innen. Beteiligte Einrichtung: National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan. Hauptthemen laut MEDLINE: Sarcoma, Soft Tissue Neoplasms. Die Arbeit nennt 4 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SarcomaSoft Tissue NeoplasmsHumansNeoadjuvant TherapyExtremitiesPerfusionChemotherapy, Cancer, Regional PerfusionRadiotherapy, AdjuvantTumor Necrosis Factor-alpha

Substanzen

Tumor Necrosis Factor-alpha

Autor:innen und Institutionen

  • National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
  • Department of Radiation Oncology, Taoyuan General Hospital, Ministry of Health and Welfare, Taoyuan, Taiwan. Electronic address: codingforlifetime@gmail.com.

Zitieren

APA

Wu, C. J., & Kao, Y. S. (2023). Isolated limb perfusion versus radiotherapy in the neoadjuvant setting of extremity soft tissue sarcoma. European Journal of Surgical Oncology. https://doi.org/10.1016/j.ejso.2023.04.014

Vancouver

Wu CJ, Kao YS. Isolated limb perfusion versus radiotherapy in the neoadjuvant setting of extremity soft tissue sarcoma. European Journal of Surgical Oncology. 2023. doi:10.1016/j.ejso.2023.04.014

BibTeX
@article{Wu2023,
  author = {Wu, Cheng-Ju and Kao, Yung-Shuo},
  title = {Isolated limb perfusion versus radiotherapy in the neoadjuvant setting of extremity soft tissue sarcoma},
  journal = {European Journal of Surgical Oncology},
  year = {2023},
  doi = {10.1016/j.ejso.2023.04.014}
}
Kostenlos starten →